Calciphylaxis: diagnosis, pathogenesis, and treatment

JJ Chang - Advances in skin & wound care, 2019 - journals.lww.com
Calciphylaxis is a cutaneous ischemic infarct caused by total occlusion of blood vessels
initiated by vascular calcification. Until recently, treatments have been limited to controlling …

[HTML][HTML] Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney disease

MR Weir, V Ashton, KT Moore, S Shrivastava… - American heart …, 2020 - Elsevier
Background There is limited evidence on the effectiveness and safety of direct-acting oral
anticoagulants in patients with nonvalvular atrial fibrillation (NVAF) and advanced chronic …

2016 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards

EJ Favaloro - Seminars in thrombosis and hemostasis, 2017 - thieme-connect.com
Hemostasis Awards” in honor of Eberhard Mammen (► Fig. 1) and in recognition of his
contribution to this field and to the journal that he founded and steered for over three …

Higher D‐dimer and activated partial thromboplastin time are poor prognostic factors in patients with peritoneal dialysis‐related peritonitis

YJ Huang, LP Xiong, X Zhang, JF Zhou… - Therapeutic …, 2023 - Wiley Online Library
Introduction Coagulation system dysfunction is associated with adverse outcomes of
peritoneal dialysis (PD) and bacterial infection. We investigated the association between …

Protocol for a randomised controlled trial comparing warfarin with no oral anticoagulation in patients with atrial fibrillation on chronic dialysis: the Danish Warfarin …

ELF Ballegaard, K Lindhard, M Lindhardt, CD Peters… - BMJ open, 2024 - bmjopen.bmj.com
Introduction Atrial fibrillation is highly prevalent in patients on chronic dialysis. It is unclear
whether anticoagulant therapy for stroke prevention is beneficial in these patients. Vitamin K …

Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis

W Li, Y Zhou, S Chen, D Zeng, H Zhang - Frontiers in Cardiovascular …, 2022 - frontiersin.org
Background Non-vitamin K antagonist oral anticoagulants (NOACs) showed a benefit-risk
profile superior to that of warfarin in atrial fibrillation (AF) patients with mild to moderate …

[PDF][PDF] The use of anticoagulants in chronic kidney disease: Common point of view of cardiologists and nephrologists

J Domienik-Karłowicz, O Tronina, W Lisik… - Cardiology …, 2020 - journals.viamedica.pl
In patients diagnosed with chronic kidney disease (CKD), atrial fibrillation (AF) is associated
with an increased risk of thromboembolism and stroke. Moreover, patients with CKD …

Venous thromboembolism and renal impairment: insights from the SWIss Venous ThromboEmbolism Registry (SWIVTER)

D Spirk, T Sebastian, M Banyai, JH Beer… - … in thrombosis and …, 2019 - thieme-connect.com
Renal impairment (RI) has increased substantially over the last decades. In the absence of
data from confirmatory research, real-life data on anticoagulation treatment and clinical …

2019 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards

EJ Favaloro - Seminars in Thrombosis and Hemostasis, 2020 - thieme-connect.com
Welcome to another of our Eberhard F. Mammen award announcements. As noted many
times previously, Thieme, the publisher of Seminars in Thrombosis & Hemostasis (STH), has …

Recent Advances in Thrombosis and Hemostasis–Part III

S Schulman - Seminars in Thrombosis and Hemostasis, 2018 - thieme-connect.com
The idiom, in similar wording, actually originates from the old Greek philosophers. This idiom
is often used today to illustrate any experience or perception that is subjective and personal …